Effectiveness of Erythropoiesis-Stimulating Agent Therapy with Oral and Intravenous Iron Supplementation in Achieving Hemoglobin Targets in Stage 5 Chronic Kidney Disease Patients. (2026). JURNAL FARMASIMED (JFM), 9(1), 499-507. https://doi.org/10.35451/jfm.v9i1.3691